Carregando...
Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer
Lung cancer is the leading cause of cancer death in men and women. Lung adenocarcinoma (LUAD), represents approximately 40% of all lung cancer cases. Advances in recent years, such as the identification of oncogenes and the use of immunotherapies, have changed the treatment of LUAD. Yet survival rat...
Na minha lista:
| Publicado no: | Front Immunol |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6522855/ https://ncbi.nlm.nih.gov/pubmed/31134065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.00954 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|